Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now includes a Results section with primary and secondary outcomes and updated study dates (start, primary completion, study completion) and enrollment. This provides current information about the trial findings and status.SummaryDifference0.4%

- Check23 days agoChange DetectedDeleted a MedlinePlus Genetics topic related to Prostate cancer, removing it from the page's core topics.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference2%

- Check37 days agoChange DetectedAdded MedlinePlus Genetics topic: Prostate cancer and updated the revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check44 days agoChange Detected- Removed a MedlinePlus Genetics topic on Prostate cancer, reducing genetic-disease content and potentially narrowing the scope of informational topics available on the page.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page version has been updated from v3.0.1 to v3.0.2. The 'Back to Top' control has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.